| |
| |
|
| Insider
Information: |
Schwartz Jeffrey Lawrence |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
10,572 |
|
|
Indirect Shares
|
16,348,152 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$38,533,381 |
|
|
| Total
Shares |
16,358,724 |
|
|
| Total
Value |
$38,533,381 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aptinyx Inc. |
APTX |
10% Owner |
|
0 |
2020-01-14 |
5,558,425 |
Premium* |
|
|
Arcutis Biotherapeutics, Inc. |
ARQT |
10% Owner |
2020-02-04 |
0 |
2020-02-04 |
3,979,292 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
3,241,628 |
Premium* |
|
|
Bcls Acquisition Corp. |
BLSA |
Chief Executive Office... |
2020-10-26 |
0 |
2020-10-26 |
487,500 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director |
2023-05-24 |
10,572 |
2023-05-24 |
3,081,307 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,648 |
10,572 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-03-16 |
4 |
S |
$28.50 |
$49,875,000 |
I/I |
(1,750,000) |
3,081,307 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
5,924 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
1,106 |
0 |
- |
|
| BLSA |
Bcls Acquisition Corp. |
Chief Executive Officer |
• • • |
2020-10-26 |
4 |
A |
$10.00 |
$4,875,000 |
I/I |
487,500 |
487,500 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
B |
$17.00 |
$6,800,000 |
I/I |
400,000 |
3,241,628 |
1.5 |
- |
|
| ANNX |
Annexon, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,841,628 |
2,841,628 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
10% Owner |
– – • |
2020-02-04 |
4 |
B |
$17.00 |
$4,999,989 |
I/I |
294,117 |
3,979,292 |
1.5 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
10% Owner |
– – • |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,685,175 |
3,685,175 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
10% Owner |
– – • |
2020-01-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,558,425 |
|
% |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
